# Mechanisms of Diuretic Resistance in Heart Failure, Aim 1

> **NCT05323487** · PHASE1 · RECRUITING · sponsor: **Yale University** · enrollment: 75 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Bumetanide Injection

## Key facts

- **NCT ID:** NCT05323487
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-01
- **Primary completion:** 2026-05-01
- **Final completion:** 2026-11-01
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2025-01-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05323487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05323487, "Mechanisms of Diuretic Resistance in Heart Failure, Aim 1". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05323487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*